Future of Health Data Summit 2024

At the 2024 Future of Health Data Summit in Washington DC, Datavant CEO Kyle Armbrester discussed the need for us to move beyond data connectivity and toward greater data usability.

Kyle Armbrester (CEO, Datavant) and Sarah London (CEO, Centene) participate in a fireside chat at the 2024 Future of Health Data Summit, where they discuss the role of product in healthcare innovation, Centene's approach to Medicaid and data strategy, and the potential impact of AI on healthcare administration and member experiences.

At the 2024 Future of Health Data Summit hosted by Datavant in Washington, D.C., this panel discussed the challenges and opportunities in expanding value-based care models, including policy proposals, data sharing, and incentives for providers and patients

This panel at the 2024 Future of Health Data Summit, moderated by Datavant Chief Legal Officer Kathryn Stalmack, explored the complexities of healthcare interoperability, discussing the balance between data sharing and privacy, as well as the challenges in implementing trusted frameworks across diverse healthcare entities. They emphasized the need for a mindset shift towards digital-first approaches, the importance of patient trust and transparency, and the potential for new technologies and governance models to advance interoperability while safeguarding sensitive information.

This panel discussion at Datavant’s 2024 Future of Health Data Summit focused on the challenges and opportunities in payer-provider collaboration, emphasizing the need for better data interoperability, aligned incentives, and standardization. The panelists discussed current barriers, potential solutions, and the future of healthcare data exchange, highlighting the progress made so far and the potential impact of emerging technologies like AI.

The AI panel at the 2024 Future of Health Data Summit discussed the need for greater transparency and trust-building in AI system development before these systems would be ready for regular use in clinical settings. The group recognized that the potential support offered for administrative processes and trial development provided by AI systems would only be valuable in the long run if patients trust the systems they are asked to opt into.

The patient registries panel has become a regular feature at the Future of Health Data Summit. In 2024, the panel discussed the evolution of patient registries, emphasizing their importance in collecting comprehensive data for medical research. They explored topics such as patient consent, data harmonization, AI applications, and innovations in early cancer detection, highlighting how modern technology and approaches are making registries more powerful and accessible tools for advancing healthcar

From randomized controlled trials to federated learning approaches and personalized treatments, this panel at the Future of Health Data Summit 2024 discussed real-world data's potential to revolutionize healthcare.

The panel discussion on research equity and access at the 2024 Future of Health Data Summit focused on leveraging data to improve access and adoption of medical treatments across healthcare sectors. Some topics discussed included the use of AI and biomedical knowledge graphs for drug repurposing, employing engagement AI to guide physician interactions, and utilizing epidemiological studies to optimize clinical trial site selection. The panelists emphasized the importance of patient-centered research, closing feedback loops in healthcare systems, and developing a "science of global health access" to avoid delays in bringing treatments to low-income countries.